Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00566670 · ClinicalTrials.gov registry record

Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease

A clinical trial of End Stage Renal Disease, sponsored by University of Utah.

Completed
Registry status
145
Enrollment target
2
Study locations

NCT00566670 is a study of End Stage Renal Disease that has completed, run by University of Utah. The registered enrollment target is 145 participants, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00566670, a study of End Stage Renal Disease, has completed, sponsored by University of Utah.

COMPLETED
Registry status
145 participants
Enrollment target
2
Study locations

Study Summary

National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in this population. High protein intake might improve nutritional status, but it has been argued that the state of low muscle mass, small body size and low serum protein levels is not the result of decreased dietary intake, rather a result of hypercatabolism induced by metabolic acidosis, inflammation and oxidative stress. The specific aims of this study are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake or dietary protein intake with muscle mass and arterial stiffness.

Conditions Studied

End Stage Renal Disease

Study Locations (2)

Tennessee

  • Vanderbilt University Medical Centet - Nashville

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2007-09
Est. Completion 2015-10

Sponsor

University of Utah

818 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00566670

The ClinicalTrials.gov registry entry for NCT00566670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (83% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00566670 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Utah.

Frequently Asked Questions

What is clinical trial NCT00566670 about?

NCT00566670 is a clinical study titled "Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease". National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in...

What is the current status of trial NCT00566670?

This trial is currently completed. The enrollment target is 145 participants. The study started on 2007-09. Estimated completion is 2015-10.

What conditions does trial NCT00566670 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

Who is sponsoring clinical trial NCT00566670?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00566670 being conducted?

This trial has 2 study locations across Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.